Liver transplantation for malignant disease

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 13, Issue 4, 1999, Pages 575-591

  Heneghan, Michael A ^a   O'Grady, John G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Cholangiocarcinoma; Cirrhosis; Hepatoblastoma; Hepatocellular carcinoma; Liver transplantation; Secondary malignancy

Indexed keywords

BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; LIVER TUMOR; NEUROENDOCRINE TUMOR; PATIENT SELECTION; REVIEW; SOLID TUMOR; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0033381096     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0049     Document Type: Article

References (78)

1. Starzl T E. Experience in Hepatic Transplantation. 1969;WB Saunders, Philadelphia.
2. Starzl T E. The Puzzle People. 1992;University of Pittsburgh, Pittsburgh.
3. European Liver Transplant Registry Data Analysis 05/1968-12/1997. 1998;European Liver Transplant Association, Villejuif.
4. Calne R Y, Williams R. Liver transplantation. Current Problems in Surgery. 16:1979;1-44.
5. Hermanek P, Sobin L H. TNM Classification of Malignant Tumours. 1987;Springer Verlag, Berlin.
6. Beahrs O H, Henson D E, Hutter R VP, Kennedy B J. Manual of Staging for Cancer. 1992;JB Lippincott, Philadelphia.
7. Cohen M B, Haber M M, Holly E A. Cytologic criteria to distinguish hepatocellular carcinoma from non neoplastic liver. American Journal of Clinical Pathology. 95:1991;125-130.
8. Ma C K, Zarbo R J, Frierson H F, Lee M W. Comparative immunohistochemical study of primary and metastatic carcinoma of the liver. American Journal of Clinical Pathology. 99:1993;551-557.
9. McPeake J R, O'Grady J G, Zaman S. Liver transplantation for primary hepatocellular carcinoma: tumour size and number determines outcome. Journal of Hepatology. 18:1993;226-234.
10. Miller W J, Federle M P, Campbell W L. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplant patients. American Journal of Roentgenology. 157:1991;303-306.
11. Takayasu K, Moriyama N, Maramatsu Y. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. American Journal of Roentgenology. 155:1990;49-54.
12. Dodd G, Miller W J, Baron R L. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. American Journal of Roentgenology. 159:1992;727-733.
13. Sitzmann J V, Coleman J, Pitt H H. Preoperative assessment of malignant hepatic tumors. American Journal of Surgery. 159:1990;137-143.
14. Choi B I, Park J H, Kim B H. Small hepatocellular carcinoma: detection with sonography, computed tomography (CT) angiography and lipioidol-CT. British Journal of Radiology. 62:1989;897-903.
15. Kuszyk B S, Bluemke D A, Urban B A. Portal phase contrast enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. American Journal of Roentgenology. 166:1996;91-95.
16. Ros P R, Davis G L. The incidental focal liver lesion: photon, proton, or needle. Hepatology. 27:1998;1183-1190.
17. O'Grady J G, Polson R J, Rolles K. Liver transplantation for malignant disease. Results in 93 consecutive patients. Annals of Surgery. 207:1988;373-379.
18. Koneru B, Cassavilla A, Bowman J. Liver transplantation for malignant tumors. Gastroenterology Clinics of North America. 17:1988;177-193.
19. Lthoff K M, Millis J M, Rosove M H. Is liver transplantation justified for treatment of hepatic malignancies? Archives of Surgery. 125:1990;1261-1268.
20. Ringe B, Wittekind C, Bechstein W O. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Annals of Surgery. 209:1989;88-98.
21. Iwatsuki S, Gordon R D, Shaw B J, Starzl T E. Role of liver transplantation in cancer therapy. Annals of Surgery. 202:1985;401-407.
22. Yokoyama I, Todo S, Iwatsuki S, Starzl T E. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology. 37:1990;188-193.
23. Yokoyama I, Sheahan D G, Carr B. Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplantation Proceedings. 23:1991;2194-2196.
24. Iwatsuki S, Starzl T E, Sheahan D G. Hepatic resection versus transplantation for hepatocellular carcinoma. Annals of Surgery. 214:1991;221-228.
25. Achkar J P, Araya V, Baron R L. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transplantation and Surgery. 4:1998;477-482.
26. Bismuth H, Castaing D, Ericzon B G. Hepatic transplantation in Europe. First report of the European Liver Transplant Registry. Lancet. 2:1987;674-676.
27. Dalgic A, Mirza D F, Gunson B K. Role of total hepatectomy and transplantation in hepatocellular carcinoma. Transplantation Proceedings. 26:1994;3564-3565.
28. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 110:1991;726-734.
29. McCall J, Rela M, Kallife M. Transplantation for hepatocellular carcinoma: King's College Hospital experience. Hepatology. 28:1998;241A.
30. Romani F, Belli L S, Rondinara G F. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. Journal of the American College of Surgeons. 178:1994;379-384.
31. Gonzalez-Moreno E, Loinaz C, Gomez R. Orthotopic liver transplantation in primary liver tumours. Journals of Surgical Oncology. 3:1993;74-79.
32. Mazzaferro V, Rondinara G F, Rossi G. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplantation Proceedings. 26:1994;2557-2560.
33. Haug C E, Jenkins R L, Rohrer R J. Liver transplantation for primary hepatic cancer. Transplantation. 53:1992;376-382.
34. Pilchmayr R. Is there a place for liver grafting for malignancy? Transplantation Proceedings. 20:1998;478-482.
35. Pilchmayr R, Weimann A, Oldhafer K J. Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma. European Journal of Surgical Oncology. 24:1998;60-67.
36. Ismail T, Angrisani L, Gunson B K. Primary hepatic malignancy: the role of liver transplantation. British Journal of Surgery. 77:1990;983-987.
37. Pilchmayr R, Ringe B, Wittekind C. Liver grafting for malignant tumors. Transplantation Proceedings. 21:1989;2403-2405.
38. Ringe B, Pilchmayr R, Wittekind C. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World Journal of Surgery. 15:1991;270-285.
39. Bismuth H, Morino M, Sherlock D. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. American Journal of Surgery. 163:1992;387-394.
40. Carr B I, Selby R, Madariaga J. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transplantation Proceedings. 25:1993;1128-1129.
41. Stone M J, Klintmalm G BG, Polter D. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology. 104:1993;196-202.
42. Cherqui D, Piedbois P, Pierga J Y. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. Cancer. 73:1994;2721-2726.
43. Spreafico C, Marchiano A, Regalia E. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology. 192:1994;687-690.
44. Lthoff K M, Roscove M H, Shackleton C R. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Annals of Surgery. 221:1995;734-743.
45. Slater L M, Sweet P, Stupecky M, Gupta S. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. Journal of Clinical Investigation. 77:1986;1405-1408.
46. Sonneveld P, Durie B GM, Lokhorst H M. Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet. 340:1992;225-259.
47. O'Grady J G, Johnson P J, Zaman S. Decreased rate of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporin immunosuppression. Transplantation Proceedings. 20:1988;394-396.
48. Bismuth H, Chiche L, Adam R, Castaing D. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation. Transplantation Proceedings. 25:1993;1066-1067.
49. Majno P E, Adam R, Bismuth H. Influence of preoperative transarterial lipiodol chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Annals of Surgery. 226:1997;688-703.
50. Oldhafer K J, Chavan A, Frühauf N R. Arterial chemoembolization before liver transplantation with hepatocellular carcinoma: marked tumour necrosis, but no survival benefit? Journal of Hepatology. 29:1998;953-959.
51. Adachi E, Matsumata T, Nishizaki T. Effects of preoperative transcatheter hepatic arterial chemoembolization on hepatocellular carcinoma. Cancer. 72:1993;3593-3598.
52. Wu C C, Ho Y Z, Lin Ho W. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. British Journal of Surgery. 82:1995;122-126.
53. Naguse N, Galiza G, Kohno H. Adverse events of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery. 106:1989;81-86.
54. Ryder S D, Rizzi P M, Metivier E. Chemoembolization with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut. 38:1996;125-128.
55. Rizzi P M, Ryder S D, Ramage J K. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. Transplantation Proceedings. 26:1994;3568-3569.
56. Edmondson H A. Differential diagnosis of tumors and tumor-like lesions of the liver in infancy and childhood. American Journal of Diseases of Children. 91:1956;168-186.
57. Craig J P, Peters R L, Edmondson H A. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer. 46:1980;372-379.
58. Starzl T E, Iwatsuki S, Shaw B J. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surgery, Gynecology and Obstetrics. 162:1986;145-148.
59. Marsh J W, Iwatsuki S, Makowka L. Orthotopic liver transplantation for primary sclerosing cholangitis. Annals of Surgery. 207:1988;21-25.
60. Steiber A C, Marino A R, Iwatsuki S. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. International Surgery. 74:1989;1-3.
61. Ismail T, Angrisani L, Powell J E. Primary sclerosing cholangitis surgical options, prognostic variables and outcomes. British Journal of Surgery. 78:1991;564-567.
62. Miros M, Kerlin P, Walker N. predicting cholangiocarcinoma in patients with cholangiocarcinoma before transplantation. Gut. 32:1991;1369-1373.
63. Farrant J M, Hayllar K M, Wilkinson M L. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 100:1991;1710-1717.
64. Nashan B, Schlitt H J, Tusch G. Biliary malignancies in primary sclerosing cholangitis: timing for transplantation. Hepatology. 23:1996;1105-1111.
65. Wiesner R H, Porayko M K, Dickson E R. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 16:1992;1290-1299.
66. Wiesner R H, Porayko M K, Hay J E. Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Liver Transplantation and Surgery. 5:1996;99-108.
67. Weiss J W, Enzinger F M. Epithelioid haemangioendothelioma: a vascular tumour often mistaken for a carcinoma. Cancer. 50:1982;970-981.
68. Scoazec J Y, Lamy P, Degott C. Epithelioid haemangioendothelioma of the liver. Diagnostic features and role of liver transplantation. Gastroenterology. 94:1988;1447-1453.
69. Ishak K G, Sesterhenn I A, Goodman M ZD. Epithelioid haemangioendothelioma of the liver: a clinicopathologic and follow up study of 32 cases. Human Pathology. 15:1984;839.
70. Clements D, Hubscher S, West R. Epithelioid haemangioendothelioma. A case report. Journal of Hepatology. 2:1986;441-449.
71. Marino I R, Todo S, Tzakis A G. Treatment of hepatic epithelioid haemangioendothelioma with liver transplantation. Cancer. 61:1988;2079-2084.
72. Arnold J C, O'Grady J G, Bird G L. Liver transplantation for primary and secondary apudomas. British Journal of Surgery. 76:1989;248-249.
73. Makowka K, Tzakis A G, Mazzoferro V. Transplantation of the liver for metastatic endocrine tumours of the intestine and pancreas. Surgery, Gynecology and Obstetrics. 168:1989;107-111.
74. Iwatsuki S. Liver transplantation for metastatic hepatic malignancy. Busuttil R W, Klintmalm G B. Transplantation of the Liver. 1996;130-133 WB Saunders, Philadelphia.
75. Koneru B, Flye M W, Busuttil R W. Liver transplantation for hepatoblastoma. The American experience. Annals of Surgery. 213:1991;118-121.
76. Ryckman F C, Alonso M H. Transplantation for primary hepatic malignancy in children. Busuttil R W, Klintmalm G B. Transplantation of the Liver. 1996;216-226 WB Saunders, Philadelphia.
77. Mieles L A, Esquivel C O, Van Thiel D H. Liver transplantation for tyrosinaemia: a review of 10 cases from the University of Pittsburgh. Digestive Diseases and Science. 35:1990;153-157.
78. Weinberg A C, Mize C E, Worthen H G. The occurrence of hepatoma in the chronic form of hereditary tyrosinaemia. Journal of Paediatrics. 88:1976;434-438.